These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22021428)

  • 1. GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer.
    Wang Y; He X; Ngeow J; Eng C
    Hum Mol Genet; 2012 Feb; 21(3):569-76. PubMed ID: 22021428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
    Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
    Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
    Lin HK; Hu YC; Lee DK; Chang C
    Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.
    Wang Y; Romigh T; He X; Tan MH; Orloff MS; Silverman RH; Heston WD; Eng C
    Oncogene; 2011 Oct; 30(42):4327-38. PubMed ID: 21532617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
    Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
    Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition.
    Lee JY; Kang MB; Jang SH; Qian T; Kim HJ; Kim CH; Kim Y; Kong G
    Oncogene; 2009 Feb; 28(6):824-31. PubMed ID: 19079342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cell proliferation and migration by keratin19-induced nuclear import of early growth response-1 in breast cancer cells.
    Ju JH; Yang W; Lee KM; Oh S; Nam K; Shim S; Shin SY; Gye MC; Chu IS; Shin I
    Clin Cancer Res; 2013 Aug; 19(16):4335-46. PubMed ID: 23833298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
    Lei Q; Jiao J; Xin L; Chang CJ; Wang S; Gao J; Gleave ME; Witte ON; Liu X; Wu H
    Cancer Cell; 2006 May; 9(5):367-78. PubMed ID: 16697957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous PTEN gene induces apoptosis in breast carcinoma cell line MDA468.
    Chen Q; Wang C; Jiang C; Chen D
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):61-4. PubMed ID: 17393112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
    Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.
    He B; Lanz RB; Fiskus W; Geng C; Yi P; Hartig SM; Rajapakshe K; Shou J; Wei L; Shah SS; Foley C; Chew SA; Eedunuri VK; Bedoya DJ; Feng Q; Minami T; Mitsiades CS; Frolov A; Weigel NL; Hilsenbeck SG; Rosen DG; Palzkill T; Ittmann MM; Song Y; Coarfa C; O'Malley BW; Mitsiades N
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18261-6. PubMed ID: 25489091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.
    Ma Q; Fu W; Li P; Nicosia SV; Jenster G; Zhang X; Bai W
    Mol Endocrinol; 2009 Feb; 23(2):213-25. PubMed ID: 19074551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.
    Ghosh-Choudhury N; Mandal CC; Ghosh-Choudhury N; Ghosh Choudhury G
    Cell Signal; 2010 May; 22(5):749-58. PubMed ID: 20060890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas.
    Wang Y; He X; Yu Q; Eng C
    Hum Mol Genet; 2013 Jun; 22(11):2263-72. PubMed ID: 23418309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
    Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
    Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
    Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
    BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.
    Seo WY; Jeong BC; Yu EJ; Kim HJ; Kim SH; Lim JE; Kwon GY; Lee HM; Kim JH
    Nucleic Acids Res; 2013 Oct; 41(18):8526-36. PubMed ID: 23887938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.